Hackensack Meridian Health Cardiovascular Care
Advancing heart and vascular care through technology, expertise and research
The cardiovascular programs at Hackensack University Medical Center and Jersey Shore University Medical Center are leading the way with powerful programs to identify, treat and manage heart and vascular conditions. Their exceptional teams embrace innovative solutions, demonstrate a commitment to quality outcomes, and work to bring education and research breakthroughs to the bedside.
Hackensack University Medical Center Cardiac Surgeons First in World to Implant FDA-Approved Impella RP Flex Heart Pump
The first-in-human Impella RP Flex implant procedure used minimally invasive catheter-based approach to treat right heart failure
TEE Fusion Imaging Brings Precision View to TMVR
Case study demonstrates capability of 3D image overlay to precisely pinpoint and address mitral paravalvular leak
Hackensack University Medical Center Second Hospital Worldwide to Implant Impella BTR Minimally Invasive Heart Pump
One of only five sites in the U.S. selected to participate in early clinical trial for the minimally invasive Advanced HF technology
Hackensack University Medical Center Contributes to New TEE Screening Guidelines for Structural Heart Intervention
American Society of Echocardiography issues prescreening recommendations for accurate structural or valvular dysfunction detail
Hackensack University Medical Center Receives Mitral Valve Repair Reference Center Award
Center’s successful outcomes recognized by American Heart Association and Mitral Valve Foundation distinction
Hackensack University Medical Center a Global Leader for PROTECT IV Trial Enrollment
Clinical trial evaluating long-term effectiveness of percutaneous revascularization with Impella® pump support for high-risk patients
New Jersey’s First Dual-Chamber Leadless Pacemakers Implanted at Jersey Shore University Medical Center
Aveir TM DR i2i clinical study studies synchronized two-chamber communication with minimally invasive implant procedure benefit
Jersey Shore University Medical Center Enrolled Patients in AGENT IDE Clinical Trial
Only hospital site in N.J. to offer balloon device for in-stent restenosis following a previous coronary stenting through angioplasty
Jersey Shore University Medical Center Joins APOLLO Trial
Evaluating the Intrepid Transcatheter Mitral Valve Replacement System for patients with severe symptomatic mitral regurgitation
Jersey Shore University Medical Center Physicians Name Top Heart Failure Developments
Physician thought leaders comment on game-changing device and drug treatments with significant HF patient outcome impact